HC Wainwright maintains Kyntra Bio price target at $43.00
HC Wainwright & Co. maintained a $43.00/share price target for Kyntra Bio, per Benzinga ratings actions.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.